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Adipose tissue insulin resistance and inflammation, but not reduced hepatic fat oxidation, are associated to active NASH and severe liver fibrosis.
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Background and aims: The mechanisms that are involved in the progression of steatosis (NAFL) to NASH and to advanced liver disease are not completely elucidated. Reduced liver mitochondrial fat oxidation and VLDL secretion as consequences of increased fat overflow to the liver are implicated. Thus, we hypothesized that subjects with more severe NAFLD/NASH are those with increased adipose tissue (AT) insulin resistance (Adipo-IR, reflecting the impaired suppression of lipolysis), reduced beta hydroxybutyrate (BOH, reflecting hepatic mitochondrial fat oxidation) and reduced apolipoprotein B (ApoB), a rate limiting factor for VLDL secretion and thus implicated in the secretion of hepatic triglyceride (TG).
Methods: In 318 histologically characterized NAFLD subjects (188 of which had NASH) in the EPoS European NAFLD Registry we measured circulating markers of AT dysfunction i.e., free fatty acid (FFA) and Adipo-IR=FFAxIns, AT inflammation (i.e. leptin, adiponectin, TNF-α and MCP-1), hepatic lipid oxidation (BOH) and secretion (TG and ApoB). Data were analysed by logistic multivariable analysis (LMA) adjusted for age, gender and BMI and odd ratios (OR) were calculated.
Results: Subjects with NASH had higher BMI (32.9±0.4 vs 31.1±0.6 Kg/m2), Adipo-IR=FFAxIns (23.2±1.5 vs 16.3±1.6), TNF-α (4.9±0.2 vs 3.3±0.2 pg/ml), MCP-1 (112±3 vs 92±3 pg/ml), leptin (13.8±1.0 vs 10.4±1.0 ng/ml) and reduced adiponectin (11.0±0.6 vs 13.5±0.8 ug/ml), all p<0.001 while TG (213±37 mg/dl), ApoB (77±2 mg/dl), BOH (99±9 umol/l) and FFA (0.76±0.02 mmol/l) were similar in the two groups. 
Dysfunctional AT (showed by increased Adipo-IR) was independently associated with increased steatosis (OR=8.3), presence of active NASH (OR=3.1) and fibrosis F3-F4 (OR=2.5), all p<0.001. 
Surprisingly, hepatic mitochondrial fat oxidation, reflected by BOH, was not reduced, but rather increased in subjects with F3-4 and associated with adipo-IR, ie with the overflow of fat from the adipose tissue to the liver (p<0.0001). Adipo-IR was strongly positively correlated also with TG, leptin, TNF-α and MCP-1 concentration (p<0.0001).
Conclusions: Severity of NAFLD is strongly associated with markers of AT dysfunction and inflammation while mitochondrial beta oxidation does not appear to be dysfunctional, indicating once again the importance of AT in the progression of NAFL to NASH.
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